US based startup MicroBiome Therapeutics, (MBT), a leading company applying the science of the gastrointestinal (GI) microbiome to promote health and wellness, recently announced the launch of BiomeBliss, a patented, first-in-class prebiotic dietary supplement specifically developed to support a healthy GI microbiome. Developed by pioneering researchers and entrepreneurs, BiomeBliss nourishes, shifts and protects the GI microbiome ‒ the trillions of gut bacteria that affect health.
Two rigorous clinical studies conducted by Pennington Biomedical Research Center, a leading center of clinical nutrition research, show BiomeBliss helps control hunger, promotes regularity and supports overall health of the GI microbiome. Study results also show BiomeBliss helps maintain healthy mealtime blood sugar levels when already in the normal range.
BiomeBliss is a natural, berry-flavored powder that mixes easily with water for a delicious, convenient drink. Made with nutrients isolated from blueberries, agave and oats, BiomeBliss supplies key prebiotics to the GI microbiome that are often missing from modern diet, such as inulin, Polyphenol antioxidants and Beta-glucan.